{"disease":{"id":"adverse-drug-reactions","name":"adverse drug reactions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04279470","title":"Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT02097654","title":"Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons","phase":"NA","overall_status":"COMPLETED","enrollment_count":1537,"lead_sponsor_name":"University College Cork","has_results":false},{"nct_id":"NCT04252326","title":"The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT04743544","title":"Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy","phase":"","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT04547335","title":"The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole","phase":"","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT06456086","title":"Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":27,"lead_sponsor_name":"First Affiliated Hospital of Kunming Medical University","has_results":false},{"nct_id":"NCT07110662","title":"New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}